# DALVANCE
> **NDA021883** · New Drug Application · Sponsor: ABBVIE · Approved 2014-05-23
## Drug
- **FDA Application Number:** NDA021883
- **Application type:** New Drug Application
- **Brand name:** DALVANCE
- **Generic name:** DALBAVANCIN
- **Active ingredients:** DALBAVANCIN HYDROCHLORIDE
- **Dosage form:** POWDER
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** ABBVIE
- **Manufacturer:** Allergan, Inc.
- **First approval:** 2014-05-23
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021883)
---
*MORVS · CC0 1.0*